RESUMO
BACKGROUND: microRNAs (miRNAs) are single-stranded, noncoding RNA molecules. Given the vast regulatory potential of miRNAs and their often tissue-specific and disease-specific expression patterns, miRNAs are being assessed as possible biomarkers to aid diagnosis and prediction of different types and stages of cancers, including skin cancer. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common forms of nonmelanoma skin cancer (NMSC). BCC originates from the basal layer of the epidermis, while SCC arises from epidermal keratinocytes or from the dermal appendages. Although NMSCs are currently the most common types of malignancies, both BCC and SCC have a better than 95% cure rate if detected early. AIM: To identify plasma miRNAs suitable for early detection of NMSC. METHODS: Expression profiles of 741 miRNAs were evaluated using high-throughput real-time quantitative PCR from plasma samples in 42 patients with NMSC and 282 healthy controls (HCs). RESULTS: Our results demonstrated that in patients with NMSC, compared with HCs, expression levels of miR-30e-3p, miR-145-5p, miR-186-5p and miR-875-5p were significantly (P < 0.05) upregulated, while those of miR-19a-3p, miR-25-3p, miR-30a-5p, miR-451 and miR-576-3p were significantly downregulated. CONCLUSION: Our study suggests that the miRNAs with significant changes in expression (miR-19a-3p, miR-25-3p, miR-30a-5p, miR-145-5p and miR-186-5p) could serve as novel noninvasive biomarkers for detection of NMSC.
Assuntos
Carcinoma Basocelular/diagnóstico , Carcinoma de Células Escamosas/diagnóstico , Detecção Precoce de Câncer/métodos , MicroRNAs/sangue , Biomarcadores Tumorais , Feminino , Perfilação da Expressão Gênica , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias CutâneasRESUMO
Incontinentia pigmenti (IP) is a rare genodermatosis caused by a mutation of nuclear factor kappa B essential modulator gene. There is no specific treatment for IP, therefore it has been claimed that there is no effective treatment to hasten resolution of any of the phases of IP. However, the initial vesiculobullous stage of IP is characterized histopathologically by eosinophilic inflammation, which is expected to respond to corticosteroids. An 18-day-old female neonate was seen, with vesicles on her trunk and limbs diagnosed as the vesiculobullous stage of IP. The patient was treated with a double-compound cream containing a potent corticosteroid (difluocortolone valerate 0.1%) and an antiseptic (chlorquinaldol 1%), to be applied to the lesions twice daily. Five days later, resolution of the lesions was almost complete. As chlorquinaldol has no known anti-inflammatory activity, we attribute this improvement to difluocortolone valerate. This case shows that early lesions of IP with eosinophilic inflammation are treatable.
Assuntos
Clorquinaldol/administração & dosagem , Diflucortolona/análogos & derivados , Glucocorticoides/administração & dosagem , Incontinência Pigmentar/tratamento farmacológico , Administração Cutânea , Diflucortolona/administração & dosagem , Feminino , Humanos , Incontinência Pigmentar/patologia , Recém-NascidoAssuntos
Aminoquinolinas/efeitos adversos , Síndrome de Behçet/tratamento farmacológico , Toxidermias/etiologia , Indutores de Interferon/efeitos adversos , Úlcera Cutânea/induzido quimicamente , Doenças da Vulva/induzido quimicamente , Adulto , Condiloma Acuminado/tratamento farmacológico , Feminino , Humanos , ImiquimodeRESUMO
BACKGROUND: Behçet's disease (BD) is a systemic inflammatory disease with unpredictable exacerbations and remissions. The natural course of BD is not fully known. OBJECTIVES: We aimed retrospectively to determine the occurrence of the symptoms in chronological order. We also evaluated the influence of the treatment and follow-up on the clinical severity and tried to identify the factors determining severe organ involvement. METHODS: Six hundred and sixty-one patients were involved in this multicentre study. The symptoms of the disease were recorded retrospectively in the time order of the manifestations in each patient. RESULTS: Oral ulcers were the most common manifestation (100%), followed by genital ulcers (85.3%), papulopustular lesions (55.4%), erythema nodosum (44.2%), skin pathergy reaction (37.8%), and articular (33.4%) and ocular involvement (29.2%). Oral ulcers were the most common onset manifestation (88.7%). The mean +/- SD duration between the onset symptom and the fulfilment of diagnostic criteria was calculated to be 4.3 +/- 5.7 years. The clinical severity score was significantly increased in the noncompliant treatment group compared with the compliant group with the passage of time (P < 0.001). The frequency of ocular involvement and genital ulcers was significantly higher in patients whose disease onset was at < 40 years. Genital ulcers, ocular involvement, papulopustular lesions, thrombophlebitis and skin pathergy reaction were found to be significantly more frequent in males. CONCLUSIONS: Mucocutaneous lesions are the hallmarks of the disease, and especially oral ulcers precede other manifestations. The increase in clinical severity score is more pronounced in patients without regular treatment and follow-up. Male sex and a younger age at onset are associated with more severe disease.
Assuntos
Síndrome de Behçet/complicações , Úlceras Orais/etiologia , Adulto , Idade de Início , Análise de Variância , Oftalmopatias/etiologia , Feminino , Gastroenteropatias/etiologia , Humanos , Artropatias/etiologia , Masculino , Doenças do Sistema Nervoso/etiologia , Estudos Retrospectivos , Dermatopatias/etiologia , Estatísticas não Paramétricas , Resultado do Tratamento , Turquia , Doenças Vasculares/etiologiaAssuntos
Ácido Micofenólico/uso terapêutico , Penfigoide Bolhoso/tratamento farmacológico , Idoso , Anti-Inflamatórios/uso terapêutico , Complemento C3/análise , Feminino , Técnica Direta de Fluorescência para Anticorpo , Glucocorticoides/uso terapêutico , Humanos , Imunoglobulina G/análise , Imunossupressores/administração & dosagem , Imunossupressores/uso terapêutico , Ácido Micofenólico/administração & dosagem , Prednisolona/uso terapêutico , Comprimidos com Revestimento EntéricoAssuntos
Fator Estimulador de Colônias de Granulócitos e Macrófagos/administração & dosagem , Úlcera da Perna/tratamento farmacológico , Úlcera da Perna/etiologia , Poliarterite Nodosa/complicações , Poliarterite Nodosa/tratamento farmacológico , Adulto , Doença Crônica , Feminino , Humanos , Injeções Intralesionais , Cicatrização/efeitos dos fármacosAssuntos
Doenças em Gêmeos/diagnóstico por imagem , Doenças em Gêmeos/patologia , Deformidades Congênitas do Pé/diagnóstico por imagem , Ceratodermia Palmar e Plantar/patologia , Ossos do Metatarso/anormalidades , Criança , Feminino , Humanos , Ossos do Metatarso/diagnóstico por imagem , Radiografia , Gêmeos MonozigóticosRESUMO
BACKGROUND: Eruptive vellus hair cysts are uncommon developmental anomalies of vellus hair follicles that are observed in young patients. Two patients were evaluated for asymptomatic flesh-coloured papules appearing on the chest, abdomen and axillae. Lesions of both patients were diagnosed histologically as eruptive vellus hair cyst, which is a disorder with no standard treatment option. OBJECTIVE: To introduce an alternative treatment and diagnostic technique for eruptive vellus hair cysts and to evaluate this technique's effectiveness histopathologically. MATERIALS AND METHODS: We treated the lesions by using cautery and a standard dissecting forceps under topical anaesthesia. After puncturing the overlying skin in the centre using the sharp-tipped cautery point, we grasped the base of the cyst using a standard dissecting forceps and we extracted the cysts out. In patient 1, extracted cysts were sent for histopathological examination; in patient 2, microscopic examination of the extracted material was performed in potassium hydroxide preparations. RESULTS: Over 150 cysts were extracted with this technique in two patients. The technique was simple, quick and tolerated well. No lesion recurrence was observed after 4 months. On histopathological examination, extracted cysts were observed to have cyst walls. In patient 2, the diagnosis was made within minutes by microscopic examination of the potassium hydroxide preparations of the extracted material. CONCLUSION: Our extraction technique is a simple and effective treatment option for these cysts. It can be regarded as curative since the cyst walls were also extracted. Microscopic examination of the potassium hydroxide preparation of the extracted cysts suggests that this technique can also be used as a simple diagnostic procedure.
Assuntos
Cisto Epidérmico/diagnóstico , Cisto Epidérmico/cirurgia , Cabelo/patologia , Dermatopatias/diagnóstico , Dermatopatias/cirurgia , Adolescente , Adulto , Cauterização/métodos , Diagnóstico Diferencial , Cisto Epidérmico/patologia , Feminino , Humanos , Masculino , Dermatopatias/patologiaRESUMO
BACKGROUND: Apolipoprotein E (apoE) phenotypes and lipoprotein compositions in xanthelasma patients have been reported in different series. OBJECTIVE: To investigate the apoE polymorphism and lipoprotein compositions in xanthelasma patients by using rapid polymerase chain reaction, and searched for an association between apoE polymorphism and the lipoprotein levels in xanthelasma patients. DESIGN: ApoE polymorphism and the different types of serum lipoproteins were studied in 25 patients with xanthelasma and compared with 27 normal subjects. RESULTS: All of patients were found to be normolipidaemic. The patients had significantly higher concentrations of total cholesterol and apolipoprotein B, and lower concentrations of apolipoprotein A. There was no difference in serum triglyceride, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol concentrations. The distribution of apoE genotypes and alleles was the same in both groups. CONCLUSIONS: The apoB, apoA and cholesterol levels did show statistically significant differences in the direction of an increased risk of atherosclerosis. Patients with xanthelasma demonstrated slight differentiations in the apoE polymorphism and metabolism of lipoproteins that require further clarifications.
Assuntos
Apolipoproteínas E/genética , Lipoproteínas/sangue , Xantomatose/genética , Apolipoproteínas A/sangue , Apolipoproteínas B/sangue , Apolipoproteínas E/sangue , Estudos de Casos e Controles , Colesterol/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético , Triglicerídeos/sangue , Turquia , População Branca/genética , Xantomatose/sangueAssuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Hipersensibilidade a Drogas/diagnóstico , Linfoma não Hodgkin/tratamento farmacológico , Adulto , Braço , Citarabina/administração & dosagem , Citarabina/efeitos adversos , Diagnóstico Diferencial , Hipersensibilidade a Drogas/etiologia , Hipersensibilidade a Drogas/patologia , Feminino , Humanos , Metotrexato/administração & dosagem , Metotrexato/efeitos adversos , Raios Ultravioleta/efeitos adversosAssuntos
Doença de Darier/diagnóstico , Nefropatias/diagnóstico , Adulto , Doença de Darier/complicações , Doença de Darier/patologia , Diagnóstico Diferencial , Humanos , Nefropatias/complicações , Nefropatias/diagnóstico por imagem , Nefropatias/patologia , Perna (Membro) , Masculino , Prurido/etiologia , Tomografia Computadorizada por Raios XRESUMO
Idiopathic guttate hypomelanosis (IGH) is a common but often unrecognized skin disease with obscure etiopathogenesis. As the lesions mostly develop on the exposed parts of the extremities, ultraviolet has been hypothesized to induce these lesions. However, previous statistical studies did not confirm any association between ultraviolet and IGH. We describe a 72-year-old woman with mycosis fungoides in whom widespread IGH occurred during narrow band ultraviolet B (UVB) therapy. The lesion development in the trunk following narrow band UVB therapy suggests that these lesions may not be idiopathic and they may be associated with UV exposure although controversy exist in the literature. This case is particular as it reveals strong evidence on this relationship.
Assuntos
Hipopigmentação/patologia , Micose Fungoide/patologia , Neoplasias Cutâneas/patologia , Terapia Ultravioleta , Idoso , Feminino , Humanos , Hipopigmentação/etiologia , Micose Fungoide/complicações , Micose Fungoide/radioterapia , Neoplasias Cutâneas/complicações , Neoplasias Cutâneas/radioterapia , Terapia Ultravioleta/efeitos adversosRESUMO
Favre-Racouchot disease (FRD) is a common disease characterized by solar elastosis and large open comedones and cysts. This disorder mainly affects elderly Caucasian men who have had a great deal of exposure to the sun. Patients having FRD continuously develop numerous large open comedones that could cause a cosmetic problem. We performed a simple and effective extraction technique for these open comedones using a standard dissecting forceps. This technique is well tolerated and no complications were observed. We suggest this comedone extraction technique as a simple alternative treatment for this common cosmetic problem.
Assuntos
Cisto Epidérmico/terapia , Dermatoses Faciais/terapia , Idoso , Cisto Epidérmico/complicações , Cisto Epidérmico/patologia , Cisto Epidérmico/urina , Dermatoses Faciais/complicações , Dermatoses Faciais/patologia , Humanos , MasculinoRESUMO
It is possible that dietary, environmental factors and/or genetic polymorphisms in xenobiotic-metabolizing enzymes may contribute to the development of Behcet's disease. As N-acetyltransferase (NAT) 2 is an important xenobiotic-metabolizing enzyme and theoretically the nonacetylated xenobiotics may induce an autoimmune mechanism, the aim of the present study was to investigate whether the genetic polymorphism of NAT2 plays a role in susceptibility to Behcet's disease. Forty Behcet's disease patients and 82 control subjects were enrolled in the study. NAT2*5A, NAT2*6A, NAT27*A/B and NAT2*14A polymorphisms were detected by using real time PCR with LightCycler (Roche Diagnostics GmbH, Mannheim, Germany). The NAT2*5A and NAT2*6A mutant genotypes carried an increased risk of developing Behcet's disease [odds ratio (OR) = 66.29, 95% confidence interval (CI) = 8.21-535.33; and OR = 24; 95% CI = 2.04-304.98, respectively]. The NAT2*7A/B and NAT2*14A gene polymorphisms were not an increased risk for developing Behcet's disease. As a result of this study we conclude the NAT2 slow acetylator status may be a determinant in susceptibility to Behcet's disease. This finding may have implications for the theories of the pathogenesis of the disease as well as for therapeutic aspects.
Assuntos
Arilamina N-Acetiltransferase/genética , Síndrome de Behçet/genética , Polimorfismo Genético , Acetilação , Adulto , Síndrome de Behçet/enzimologia , Feminino , Predisposição Genética para Doença , Genótipo , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-IdadeRESUMO
Type-1 cytokine-producing T cells are important in the pathogenesis of psoriasis vulgaris, for which efficient therapy is provided by means of narrow-band ultraviolet-B (NB-UVB). The expression of the type-1 cytokine interferon-gamma (IFN-gamma) is regulated by interleukin-12 (IL-12), IL-15, IL-18 and IL-23; however, not much is known about the effect of this therapy on the levels of these cytokines in lesional psoriatic skin in situ. In this study, we investigated the effects of NB-UVB therapy on the expression of IFN-gamma-inducing cytokines. Ten patients with chronic plaque-type psoriasis selected to be treated with NB-UVB therapy were recruited for these experiments and the expression of cytokines IL-12, IL-15, IL-18, IL-23 and IFN-gamma in lesional psoriatic skin before, during and after therapy was determined with the help of immunohistochemistry. Double staining was performed in order to determine the cell types expressing these cytokines. The decrease in the psoriasis area and severity index was accompanied by a significant decrease in the expression of IFN-gamma, and concomitantly, significant reduction of IFN-gamma inducers -- IL-12, IL-18 and IL-23. Thus, we concluded that the decrease of IFN-gamma expression in psoriasis lesions after NB-UVB therapy could be a result of diminished expression of IL-12, IL-18 and IL-23 in lesional skin. Therapies targeting these three cytokines should, therefore, be considered in the treatment of psoriasis.
Assuntos
Interferon gama/metabolismo , Interleucina-12/biossíntese , Interleucina-18/biossíntese , Interleucinas/biossíntese , Psoríase/metabolismo , Psoríase/radioterapia , Raios Ultravioleta , Adulto , Feminino , Humanos , Imuno-Histoquímica , Interleucina-23 , Subunidade p19 da Interleucina-23 , Masculino , Pessoa de Meia-IdadeRESUMO
Behçet's disease is a chronic inflammatory disorder of unknown aetiology, characterized by recurrent attacks. Pulmonary artery aneurysm is a rare but serious complication of Behçet's disease. We describe a patient with Behçet's disease and protein C and S deficiency who developed bilateral pulmonary artery aneurysms.
Assuntos
Aneurisma/diagnóstico , Síndrome de Behçet/diagnóstico , Deficiência de Proteína C/diagnóstico , Deficiência de Proteína S/diagnóstico , Artéria Pulmonar , Adulto , Aneurisma/complicações , Angiografia/métodos , Síndrome de Behçet/complicações , Análise Química do Sangue , Ecocardiografia Doppler , Seguimentos , Humanos , Masculino , Deficiência de Proteína C/complicações , Deficiência de Proteína S/complicações , Radiografia Torácica , Medição de Risco , Índice de Gravidade de Doença , Tomografia Computadorizada por Raios XRESUMO
Pyogenic granuloma is a common benign skin tumour. However, giant recurrent pyogenic granuloma with satellitosis is relatively rare. We present a 52-year-old man who had recurrent gigantic pyogenic granuloma with satellitosis responsive to systemic steroids. Our case of recurrent pyogenic granuloma is interesting because of its clinical presentation, recurrence following surgical excision and its steroid responsiveness. Systemic steroids may be effective in treating recurrent giant pyogenic granulomas during their high-proliferation phase.
Assuntos
Antineoplásicos Hormonais/uso terapêutico , Dermatoses Faciais/tratamento farmacológico , Glucocorticoides/uso terapêutico , Granuloma Piogênico/tratamento farmacológico , Prednisolona/uso terapêutico , Neoplasias Cutâneas/tratamento farmacológico , Dermatoses Faciais/patologia , Granuloma Piogênico/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Neuroglia/patologia , Recidiva , Neoplasias Cutâneas/patologiaRESUMO
Recurrent aphthous stomatitis (RAS) is recognized as one of the most common oral mucosal diseases worldwide. The aim of this study was to determine the oxidant/antioxidant status in erythrocyte and plasma samples from patients with RAS in comparison with healthy controls. Twenty-two patients with RAS and 23 healthy controls were recruited. Superoxide dismutase, glutathione peroxidase (GSHPx) and catalase (CAT) activities, and malondialdehyde (MDA) and antioxidant potential (AOP) levels were measured in plasma and erythrocytes from patient with RAS and controls. We found decreased CAT and GSHPx activities and AOP levels in the erythrocytes, and decreased AOP and increased MDA plasma levels in patients with RAS in comparison with control subjects. In summary, this study demonstrated that enzymatic and nonenzymatic antioxidant defence systems are impaired in patients with RAS.